Allergic Immunologic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC1-25

DiraChart Clinical Reference
Protected section 25 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 25 of 25PreviousDocument Menu

19. Sources and clinical references

MASTER-level citations, current as of the version date. Companies and agencies may append local policy. Verify the current edition at use; CHAP is agency-fill.

  • Anaphylaxis — A 2023 Practice Parameter Update (Joint Task Force on Practice Parameters; AAAAI/ACAAI) — recognition and epinephrine-first management (verify current update).
  • Clinical guidance on immunocompromised-host infection and neutropenic fever (verify current source; cross-reference Hematologic).
  • Immunization guidance for immunosuppressed adults (verify current source).
  • CMS Medicare Benefit Policy Manual (Pub. 100-02), Chapter 7 — Home Health Services. Observation and assessment, skilled procedures, and teaching and training.
  • 42 CFR Part 484 — Conditions of Participation for Home Health Agencies; comprehensive assessment and care planning.
  • CMS OASIS-E2 Guidance Manual, effective April 1, 2026 — relevant clinical items.
  • Community Health Accreditation Partner (CHAP) Standards of Excellence for Home Health. [Agency-fill: insert exact title, version, section, and date.]
Section NavigationPart 25 of 25PreviousDocument Menu